Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.5650
+0.0050 (0.32%)
NASDAQ · Last Trade: Feb 5th, 11:44 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors